Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
By Sharon Sharma
Preclinical studies of lipid lowering drugs Statin has shown anti-proliferative, pro-apoptotic and radio-sensitising properties. Can it be used in patients treated with radiotherapy for prostate cancer? According to the study published first online in Journal of Clinical Oncology, April 26, Statin use in Prostate cancer treated with radiotherapy resulted in a significant improvement in freedom from biochemical failure, freedom from androgen deprivation therapy and relapse-free survival. Improved survival in statin users occurred in all risk groups of cancer and was independent of androgen deprivation therapy or radiotherapy. The favourable effect of statins may be mediated by direct effect or via the LDL-lowering effect of these medications.
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.